Open Access
Issue
Med Sci (Paris)
Volume 35, Number 1, Janvier 2019
Page(s) 26 - 29
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2018316
Published online 23 January 2019
  1. Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 2017 ; 16 :115–130. [CrossRef] [PubMed] [Google Scholar]
  2. Laustriat D, Gide J, Héchard C, Peschanski M. Les cellules souches embryonnaires et la pharmacologie. Med Sci (Paris) 2009 ; 25 :32–38. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Bassez G, Audureau E, Hogrel JY, et al. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain 2018 ; 141 :2855–2865. [CrossRef] [PubMed] [Google Scholar]
  4. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998 ; 282 :1145–1147. [Google Scholar]
  5. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 ; 131 :861–872. [CrossRef] [PubMed] [Google Scholar]
  6. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 ; 318 :1917–1920. [Google Scholar]
  7. Peschanski M. Cellules souches : l’heure est venue du changement d’échelle. Med Sci (Paris) 2018; 24 :335–8. [Google Scholar]
  8. Baertschi Bernard. Le diagnostic préimplantatoire (DPI) à l’ère de la médecine prédictive. Med Sci (Paris) 2019 ; 35 :72–77. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Marteyn A, Maury Y, Gauthier MM, et al. Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell 2011 ; 8 :434–444. [Google Scholar]
  10. Denis JA, Gauthier M, Rachdi L, et al. mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1. J Cell Sci 2013 ; 126 :1763–1772. [Google Scholar]
  11. Gauthier M, Marteyn A, Denis JA, et al. A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1. Hum Mol Genet 2013 ; 22 :5188–5198. [CrossRef] [PubMed] [Google Scholar]
  12. Laustriat D, Gide J, Barrault L, et al. In vitro and in vivo modulation of alternative splicing by the biguanide metformin. Mol Ther Nucleic Acids 2015 ; 4 :e262. [CrossRef] [PubMed] [Google Scholar]
  13. Martinat C, Peschanski M. L’heure est venue d’un (re)positionnement thérapeutique des maladies ultra-rares. Med Sci (Paris) 2018 ; 34 :1019–1020. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.